COVID‐19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data

BACKGROUND: Adherence to oral anticoagulation (OAC) is critical for stroke prevention in atrial fibrillation. However, the COVID‐19 pandemic may have disrupted access to such therapy. We hypothesized that our analysis of a US nationally representative pharmacy claims database would identify increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Inmaculada, Gabriel, Nico, He, Meiqi, Guo, Jingchuan, Tadrous, Mina, Suda, Katie J., Magnani, Jared W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075244/
https://www.ncbi.nlm.nih.gov/pubmed/34913359
http://dx.doi.org/10.1161/JAHA.121.023235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075244/
https://www.ncbi.nlm.nih.gov/pubmed/34913359
http://dx.doi.org/10.1161/JAHA.121.023235

Ejemplares similares